New Treatments And Lt3 (Liothyronine) Combinations / Alternative Therapies

Authors

  • Karimova Muqima Muhammadsodikovna Head of the Department of Endocrinology, Hematology, and Phthisiology, PhD
  • Djalalidinova Odina Odilovna -year Master’s student in Endocrinology

DOI:

https://doi.org/10.62480/tjms.2026.vol52.pp1-2

Keywords:

Hypothyroidism, LT4 monotherapy, LT3 combination

Abstract

This article reviews new approaches to the treatment of hypothyroidism, specifically the combination of levothyroxine (LT4) and liothyronine (LT3), as well as alternative therapies. The article provides an in-depth review of the limitations of LT4 monotherapy, the rationale for the addition of LT3, clinical trial results, safety issues, and future developments. The aim is to highlight more effective treatment options for patients with persistent symptoms and to emphasize the importance of personalized medicine.

Downloads

Published

2026-01-18

Issue

Vol. 52 (2026): TJMS

Section

Articles

License

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

User Rights

Under the Creative Commons Attribution-NonCommercial 4.0 International (CC-BY-NC), the author (s) and users are free to share (copy, distribute and transmit the contribution).

Rights of Authors

Authors retain the following rights:
1. Copyright and other proprietary rights relating to the article, such as patent rights,
2. the right to use the substance of the article in future works, including lectures and books,
3. the right to reproduce the article for own purposes, provided the copies are not offered for sale,
4. the right to self-archive the article.

How to Cite

New Treatments And Lt3 (Liothyronine) Combinations / Alternative Therapies. (2026). Texas Journal of Medical Science, 52, 1-2. https://doi.org/10.62480/tjms.2026.vol52.pp1-2